Enterprise adoption Creyos is expanding beyond academic research into clinical practice with health care providers worldwide, signaling growing enterprise adoption opportunities for hospital networks, multisite clinics, and integrated care platforms.

Data driven enablement A global normative database of over 85,000 participants and 12+ million tasks enables benchmarking and personalized cognitive assessments, presenting a compelling value proposition for hospitals and clinics pursuing outcome-based reimbursement and quality metrics.

Diversified offerings Two core products Creyos Health and Creyos Research address clinical brain health assessment and large-scale cognition studies, creating cross-sell potential to researchers, clinicians, and pharmaceutical partners seeking scalable cognitive data collection.

Strategic partnerships Recent collaborations with Redox and participation in major health and neuroscience events indicate a momentum of partnerships and visibility that can be leveraged to secure system-wide deployments, data interoperability projects, and research collaborations.

Growth signals Revenue is in the mid single to high single digits under $50M with a lean team; coupled with ongoing updates to improve accessibility, there is an opportunity to position Creyos as a cost-effective, scalable solution for cognitive assessment in diverse patient populations.